Iraqi Board Clinical Pharmacy study plan

Derive and apply one-compartment IV bolus and infusion equations to calculate Vd, CL, t1/2, and steady-state concentration from supplied plasma concentration data.

Calculate loading and maintenance doses for aminoglycosides and vancomycin using patient-specific creatinine clearance estimates (Cockcroft-Gault), then justify any dose adjustment in writing.

Interpret Michaelis-Menten (capacity-limited) kinetics for phenytoin and salicylate, and predict the effect of a dose increase on steady-state concentration.

Explain how protein binding, hepatic extraction ratio, and first-pass metabolism alter bioavailability and half-life, using two worked drug examples each.

Build a personal one-page equation sheet linking each pharmacokinetic parameter to its clinical decision (dose, interval, monitoring).

Construct guideline-concordant treatment plans for heart failure with reduced ejection fraction, sequencing all four pillar drug classes with titration triggers and monitoring parameters.

Select and titrate antihypertensive regimens by comorbidity (diabetes, chronic kidney disease, heart failure, pregnancy), stating the rationale for each add-on.

Apply the 2019 CKD-MBD and KDIGO frameworks to manage anemia, mineral bone disease, and hyperkalemia in a dialysis patient.

Evaluate anticoagulation choices in atrial fibrillation with dose-reduction criteria for direct oral anticoagulants and renal/hepatic caveats.

Interpret a lipid panel and decide statin intensity and add-on therapy for a very-high-risk secondary-prevention patient.

Match empiric antibiotic regimens to common infection syndromes (community-acquired pneumonia, urinary tract infection, sepsis, skin and soft tissue infection) using local resistance patterns and de-escalation criteria.

Apply antimicrobial stewardship principles to a supplied scenario: justify duration, IV-to-oral switch, and discontinuation using clinical stability markers.

Interpret minimum inhibitory concentration data and apply pharmacokinetic/pharmacodynamic targets (time above MIC, AUC/MIC) to optimize beta-lactam and vancomycin dosing.

Differentiate antifungal and antiviral first-line agents by spectrum, monitoring, and major drug interactions for three common scenarios.

List notifiable infections and isolation precautions relevant to Iraqi hospital practice and explain when to escalate to public health authorities.

Design insulin initiation and titration plans for type 2 diabetes, including basal-bolus conversion, correction factors, and hypoglycemia management.

Select and monitor oral and injectable antidiabetic agents by comorbidity (heart failure, CKD, obesity, cardiovascular disease) with contraindications stated.

Manage thyroid disorders: interpret TSH/free T4, dose levothyroxine, and adjust therapy in pregnancy and in patients with cardiac disease.

Apply corticosteroid stress dosing, taper schedules, and long-term adverse-effect monitoring to a patient on chronic prednisolone.

Calculate enteral and parenteral nutrition requirements (calories, protein, fluid) for a malnourished inpatient and identify refeeding syndrome risk.

Apply GOLD and asthma stepwise frameworks to select and adjust inhaler therapy, and demonstrate correct inhaler technique steps for at least three device types.

Interpret arterial blood gases and spirometry values to classify respiratory failure and severity, then state the corresponding therapy change.

Select gastroesophageal reflux disease, peptic ulcer, and Helicobacter pylori eradication regimens, including duration and confirmation-of-cure testing.

Evaluate liver function tests and Child-Pugh or MELD scores to adjust drug dosing and identify hepatotoxic risk in a cirrhotic patient.

Integrate physical examination findings (JVP, edema, crackles, ascites) with laboratory data to prioritize a problem list in a written assessment.

Build analgesic ladders for acute and cancer pain, converting between opioids with equianalgesic calculations and adding adjuvant agents by pain mechanism.

Design antidepressant and antipsychotic therapy with monitoring for metabolic effects, QT prolongation, and serotonin syndrome risk.

Select antiepileptic therapy by seizure type and interaction profile, and plan therapeutic drug monitoring for narrow-index agents.

Construct antiemetic and chemotherapy-induced nausea prophylaxis regimens by emetogenic risk, and apply growth-factor and febrile neutropenia guidance.

Identify immunosuppressant regimens for solid organ transplant and manage their major interactions and infection prophylaxis.

Classify an adverse drug reaction by causality (Naranjo or WHO-UMC) and severity, and draft a complete pharmacovigilance report using the Iraqi reporting pathway.

Apply medication reconciliation and high-alert medication safeguards to a simulated admission and discharge, documenting at least five discrepancies resolved.

Critique a randomized controlled trial using randomization, blinding, intention-to-treat, and effect-size appraisal, and state whether the result applies to a given patient.

Interpret confidence intervals, p-values, number needed to treat, and absolute versus relative risk reduction from a supplied abstract.

Formulate a focused drug information question (PICO), search strategy, and evidence-graded answer within a stated turnaround time.

Outline Iraqi pharmacy law and regulation as it governs dispensing, controlled substances, prescription requirements, and pharmacy licensing, flagging any item requiring verification against current official texts.

Apply ethical principles to four scenarios (conflict of interest, patient confidentiality, dispensing error disclosure, refusal to dispense) and justify the chosen action.

Explain the pharmacist's role in national antimicrobial resistance and drug-quality surveillance programs and the reporting obligations that follow.

Integrate all 11 domains by reviewing personal error logs and re-testing the weakest three domains under timed conditions.

Assemble a final one-page summary sheet of high-yield dosing, monitoring, and legal points for exam-day review.